Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Non-small cell lung cancer.

C M Haskell1, E C Holmes

  • 1UCLA School of Medicine.

Disease-A-Month : DM
|February 1, 1988
PubMed
Summary
This summary is machine-generated.

This review focuses on non-small cell lung cancer (NSCLC) treatment, emphasizing practical aspects like smoking cessation, early diagnosis, and staging. It details surgical, radiation, and chemotherapy options, advocating for clinical trials or individualized patient care.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reagent contamination in viromics: all that glitters is not gold.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2019
Same author

Experimental Verification of Seed Transmission of Zucchini yellow mosaic virus.

Plant disease·2019
Same author

Transgenic Virus Resistance in Crop-Wild Cucurbita pepo Does Not Prevent Vertical Transmission of Zucchini yellow mosaic virus.

Plant disease·2019
Same author

Establishment and cryptic transmission of Zika virus in Brazil and the Americas.

Nature·2017
Same author

Phylogenetic Diversity of Koala Retrovirus within a Wild Koala Population.

Journal of virology·2016
Same author

Analysis of viral (zucchini yellow mosaic virus) genetic diversity during systemic movement through a Cucurbita pepo vine.

Virus research·2014
Same journal

Disturbances due to cold.

Disease-a-month : DM·2026
Same journal

GLP-1 agonist and neuroprotection in Stroke and Parkinson's disease: A systematic review.

Disease-a-month : DM·2026
Same journal

GLP-1 receptor agonists for weight management and potential thromboembolic risk reduction in high risk population with cancer, diabetes, cardiovascular disease: A systematic review.

Disease-a-month : DM·2026
Same journal

Periodontal disease and diabetic kidney disease: A comprehensive analysis.

Disease-a-month : DM·2026
Same journal

Foreword for Glucagon-like peptide-1 receptor agonists (GLP-1) and its promise for potential benefits.

Disease-a-month : DM·2026
Same journal

Foreword for insulin autoimmune syndrome (Hirata Disease): An updated review of epidemiology, pathophysiology, clinical features, diagnosis, and management.

Disease-a-month : DM·2026
See all related articles

Area of Science:

  • Oncology
  • Pulmonology
  • Cancer Research

Background:

  • Lung cancer is a leading cause of cancer mortality in the US.
  • Non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) are the two main classifications.
  • Effective prevention strategies include smoking cessation.

Purpose of the Study:

  • To review the practical treatment aspects of non-small cell lung cancer (NSCLC).
  • To provide recommendations for smoking cessation and early diagnosis through screening.
  • To discuss contemporary diagnostic, staging, and treatment modalities for NSCLC.

Main Methods:

  • Review of current diagnostic and staging techniques using the international TNM system.
  • Analysis of treatment options including surgery, radiation therapy, and chemotherapy.

Related Experiment Videos

  • Evaluation of chemotherapy agents, combination therapy, and adjuvant treatments.

    • Main Results:

    • Surgery plays a key role in managing local NSCLC disease.
    • Newer radiation therapy techniques offer potential benefits.
    • Chemotherapy, including comparative activity of agents and combination regimens, is examined.

    Conclusions:

    • Individualized treatment approaches are crucial when clinical trials are not feasible.
    • Patient factors such as age, health status, and personal values should guide treatment decisions.
    • Participation in clinical trials for novel therapies is strongly encouraged for NSCLC patients.